{
    "id": 32165,
    "fullName": "RB1 R7fs",
    "impact": "frameshift",
    "proteinEffect": "loss of function - predicted",
    "geneVariantDescriptions": [
        {
            "description": "RB1 R7fs results in a change in the amino acid sequence of the Rb1 protein beginning at 7 of 928, likely resulting in premature truncation of the functional protein (UniProt.org). Due to the loss of all known functional domain (UniProt.org), R7fs is predicted to lead to a loss of Rb1 protein function.",
            "references": [
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 5925,
        "geneSymbol": "RB1",
        "terms": [
            "RB1",
            "OSRC",
            "p105-Rb",
            "p110-RB1",
            "pp110",
            "PPP1R130",
            "pRb",
            "RB"
        ]
    },
    "variant": "R7fs",
    "createDate": "01/21/2020",
    "updateDate": "01/21/2020",
    "referenceTranscriptCoordinates": {
        "id": 186795,
        "transcript": "NM_000321",
        "gDna": "chr13:g.(48303930_48303931)",
        "cDna": "c.(19_18)",
        "protein": "p.R7fs",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 19914,
            "approvalStatus": "Case Reports/Case Series",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a clinical case study, a patient with an advanced solid tumor developed resistance to treatment with Tagrisso (osimertinib) and was found via cell free DNA testing to harbor an EGFR exon 19 deletion, TRIM24-RET, and RB1 R7fs (PMID: 31300450).",
            "molecularProfile": {
                "id": 34672,
                "profileName": "TRIM24 - RET EGFR exon 19 del RB1 R7fs"
            },
            "therapy": {
                "id": 660,
                "therapyName": "Osimertinib",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "predicted - resistant",
            "references": [
                {
                    "id": 17588,
                    "pubMedId": 31300450,
                    "title": "Analysis of Cell-Free DNA from 32,989 Advanced Cancers Reveals Novel Co-occurring Activating RET Alterations and Oncogenic Signaling Pathway Aberrations.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/31300450"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 34669,
            "profileName": "RB1 R7fs",
            "profileTreatmentApproaches": [
                {
                    "id": 20186,
                    "name": "HDAC Inhibitor",
                    "profileName": "RB1 R7fs"
                }
            ]
        },
        {
            "id": 34671,
            "profileName": "TRIM24 - RET RB1 R7fs",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 34672,
            "profileName": "TRIM24 - RET EGFR exon 19 del RB1 R7fs",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 186795,
            "transcript": "NM_000321",
            "gDna": "chr13:g.(48303930_48303931)",
            "cDna": "c.(19_18)",
            "protein": "p.R7fs",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}